MX2011007522A - Metodos de tratamiento de la infeccion por el virus del dengue mediante vitamina d. - Google Patents
Metodos de tratamiento de la infeccion por el virus del dengue mediante vitamina d.Info
- Publication number
- MX2011007522A MX2011007522A MX2011007522A MX2011007522A MX2011007522A MX 2011007522 A MX2011007522 A MX 2011007522A MX 2011007522 A MX2011007522 A MX 2011007522A MX 2011007522 A MX2011007522 A MX 2011007522A MX 2011007522 A MX2011007522 A MX 2011007522A
- Authority
- MX
- Mexico
- Prior art keywords
- denv
- infection
- dengue virus
- vitamin
- treating
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 206010012310 Dengue fever Diseases 0.000 title 1
- 208000025729 dengue disease Diseases 0.000 title 1
- 229940046008 vitamin d Drugs 0.000 title 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 5
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 abstract 5
- 235000005282 vitamin D3 Nutrition 0.000 abstract 5
- 239000011647 vitamin D3 Substances 0.000 abstract 5
- 229940021056 vitamin d3 Drugs 0.000 abstract 5
- 208000015181 infectious disease Diseases 0.000 abstract 4
- 241000725619 Dengue virus Species 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 238000011287 therapeutic dose Methods 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 150000003722 vitamin derivatives Chemical class 0.000 abstract 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere al tratamiento de la infección ocasionada específicamente por el virus del dengue DENV de cualquiera de sus 4 serotipos conocidos, mediante la administración de la vitamina D3 (VD3), por sus propiedades anti-DENV, así como de compuestos análogos a la VD3, la invención se refiere también a las formulaciones farmacéuticas anti-DENV que contengan a la VD3 como el agente activo solas o combinadas con otros agentes terapéuticos y se refiere también a las dosis de VD3 terapéuticas tanto para inhibir la incipiente infección por el virus del dengue, como para inhibir la progresión de dicha infección a formas severas y como tratamiento profiláctico en poblaciones susceptibles a la infección por DENV.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2011007522A MX360183B (es) | 2011-07-14 | 2011-07-14 | Metodos de tratamiento de la infeccion por el virus del dengue mediante vitamina d. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2011007522A MX360183B (es) | 2011-07-14 | 2011-07-14 | Metodos de tratamiento de la infeccion por el virus del dengue mediante vitamina d. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2011007522A true MX2011007522A (es) | 2013-01-29 |
| MX360183B MX360183B (es) | 2018-10-16 |
Family
ID=48195095
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2011007522A MX360183B (es) | 2011-07-14 | 2011-07-14 | Metodos de tratamiento de la infeccion por el virus del dengue mediante vitamina d. |
Country Status (1)
| Country | Link |
|---|---|
| MX (1) | MX360183B (es) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111346079A (zh) * | 2020-02-24 | 2020-06-30 | 南方医科大学 | 细菌dna促旋酶抑制剂brd7716作为治疗和/或预防登革病毒感染的药物及其制药用途 |
-
2011
- 2011-07-14 MX MX2011007522A patent/MX360183B/es active IP Right Grant
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111346079A (zh) * | 2020-02-24 | 2020-06-30 | 南方医科大学 | 细菌dna促旋酶抑制剂brd7716作为治疗和/或预防登革病毒感染的药物及其制药用途 |
| CN111346079B (zh) * | 2020-02-24 | 2023-06-20 | 南方医科大学 | 细菌dna促旋酶抑制剂brd7716作为治疗和/或预防登革病毒感染的药物及其制药用途 |
Also Published As
| Publication number | Publication date |
|---|---|
| MX360183B (es) | 2018-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ629996A (en) | 2’- substituted carba-nucleoside analogs for antiviral treatment | |
| EA201490377A1 (ru) | Лечение рассеянного склероза комбинацией лаквинимода и глатирамера ацетата | |
| MX2013003634A (es) | Derivados policiclicos heterociclicos y metodos de uso de los mismos para el tratamiento de enfermedades virales. | |
| WO2011127333A3 (en) | Compounds for treating disease, for administering, and for pharmaceutical compositions | |
| NZ703064A (en) | Inhibitors of hepatitis c virus | |
| MY202109A (en) | Viral replication inhibitors | |
| SG10201804552WA (en) | Nanoparticle compositions, formulations thereof, and uses therefor | |
| PH12014500257A1 (en) | Inhibitors of influenza viruses replication | |
| WO2013022846A3 (en) | Flavonoid compounds | |
| MY197785A (en) | Combinations of lsd1 inhibitors for the treatment of hematological malignancies | |
| MX2013006846A (es) | Inhibidores de la replicacion de los virus de la influenza. | |
| EA201490254A1 (ru) | Комбинированное лечение гепатита с | |
| MX350746B (es) | Derivados de ciclosporina novedosos para el tratamiento y la prevención de una infección viral. | |
| MY194294A (en) | Novel viral replication inhibitors | |
| NZ708821A (en) | Lfa-1 inhibitor formulations | |
| WO2016030899A8 (en) | Methods of treating amyotrophic lateral scleroses | |
| WO2011153458A3 (en) | Compositions and methods for inhibition of or treatment of dengue virus infection | |
| HK1201189A1 (en) | Use of amphoteric surfactants for the prevention and treatment of pathogenic vaginal biofilms in vaginal infections | |
| EA201390844A1 (ru) | Комплексный состав, содержащий гидрохлорид лерканидипина и валсартан, и способ его получения | |
| MX360183B (es) | Metodos de tratamiento de la infeccion por el virus del dengue mediante vitamina d. | |
| WO2013038200A3 (en) | Neurodevelopmental disorders | |
| EA201591994A1 (ru) | Цистеин или его производное для лечения атрофического гастрита | |
| MX2016003763A (es) | Terapia de combinacion con laquinimod para tratamiento de esclerosis multiple. | |
| PH12019501907B1 (en) | Viral replication inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |